This article explores the potential of betulinic acid as both a cancer treatment and preventive agent. The study highlights betulinic acid's ability to induce apoptosis in various cancer cell types through the activation of mitochondrial pathways. Additionally, it addresses its anti-inflammatory and anti-angiogenic properties, which may contribute to its effectiveness
